Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance.

导出 OA

翻译打印收藏纠错

第一作者： Maria Daniela,Santi

第一单位： Translational Research Center, College of Dentistry, New York University, New York, NY 10010, USA.

作者： Maria Daniela,Santi ^[1] ; Morgan,Zhang ^[2] ; Naijiang,Liu ^[1] ; Chi T,Viet ^[2] ; Tongxin,Xie ^[1] ; Dane D,Jensen ^[2] ; Moran,Amit ^[3] ; Huilin,Pan ^[4] ; Yi,Ye ^[1]

作者单位： Translational Research Center, College of Dentistry, New York University, New York, NY 10010, USA. ^[1] Pain Research Center, Department of Molecular Pathobiology, College of Dentistry, New York University, New York, NY 10010, USA. ^[2] Department of Oral and Maxillofacial Surgery, School of Dentistry, Loma Linda University, Loma Linda, CA 92350, USA. ^[3] Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. ^[4] Center for Neuroscience and Pain Research, Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. ^[5]

关键词 EGFR NMDA receptor morphine tolerance oral cancer pain μ-opioid receptor

DOI 10.3390/ph16111558

PMID 38004424

发布时间 2024-04-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交